» Articles » PMID: 7035869

Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an Immunologically Active Peptide

Overview
Publisher Springer
Specialty Biochemistry
Date 1981 Dec 4
PMID 7035869
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Tuftsin, a natural occurring tetrapeptide, has been found to exhibit several biological activities connected with immune system function. Although little is known about tuftsin's 'biogenesis', much information has been gleaned about its structure-function relationships, which have shown that several features of the molecule are essential for expression of full biological activity. Furthermore, specific receptor sites for tuftsin have been found to exist exclusively on phagocytic cells. Research indicates that tuftsin binding to target cells effect intracellular calcium and cyclic nucleotide levels. Implication of these facts on tuftsin's mode of action are discussed. Basic peptidic segments resembling tuftsin are found in a variety of regulatory peptides. Questions are, therefore, raised as to the biospecificity an cross-reactivity of these sequences. Substance P, one such peptide, which binds with and activates tuftsin receptors, is described. In light of tuftsin's therapeutic potential, assays for its determination have been introduced. When applied to analyze human blood serum of normal as well as of various pathological origins, direct correlation was found between tuftsin levels and susceptibility to bacterial infections.

Citing Articles

Helminth-Based Product and the Microbiome of Mice with Lupus.

Neuman H, Mor H, Bashi T, Givol O, Watad A, Shemer A mSystems. 2019; 4(1).

PMID: 30801028 PMC: 6381224. DOI: 10.1128/mSystems.00160-18.


Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models.

Barna B, Eppstein D, Thomassen M, Nestor Jr J, Ho T, Medendorp S Cancer Immunol Immunother. 1993; 36(3):171-6.

PMID: 8439977 PMC: 11038124. DOI: 10.1007/BF01741088.


Antibacterial properties of tuftsin and its analogs.

Muzalewski F, Konopinska D Antimicrob Agents Chemother. 1984; 25(1):134-6.

PMID: 6703677 PMC: 185452. DOI: 10.1128/AAC.25.1.134.


Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatment.

Lukacs K, Berenyi E, Kavai M, Szegedi G, SZEKERKE M Cancer Immunol Immunother. 1983; 15(2):162-3.

PMID: 6553514 PMC: 11039023. DOI: 10.1007/BF00199710.


Tuftsin (Thr-Lys-Pro-Arg), a natural modulator of macrophage activity: further studies.

Bump N, NAJJAR V Mol Cell Biochem. 1984; 63(2):137-42.

PMID: 6493218 DOI: 10.1007/BF00285221.


References
1.
Stern M, Warshawsky A, Fridkin M . Facile thiolytic removal of the o-nitrophenylsulphenyl amino-protecting group. Int J Pept Protein Res. 1979; 13(3):315-9. DOI: 10.1111/j.1399-3011.1979.tb01885.x. View

2.
Bar-Shavit Z, Goldman R, Stabinsky Y, Gottlieb P, Fridkin M, Teichberg V . Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun. 1980; 94(4):1445-51. DOI: 10.1016/0006-291x(80)90581-1. View

3.
NAJJAR V . Defective phagocytosis due to deficiencies involving the tetrapeptide tuftsin. J Pediatr. 1975; 87(6 Pt 2):1121-4. DOI: 10.1016/s0022-3476(75)80125-9. View

4.
Maganiello V, Vaughan M . Prostaglandin E 1 effects on adenosine 3':5'-cyclic monophosphate concentration and phosphodiesterase activity in fibroblasts (mouse L cells-tissue culture-enzyme kinetics-prostaglandin homologues). Proc Natl Acad Sci U S A. 1972; 69(1):269-73. PMC: 427589. DOI: 10.1073/pnas.69.1.269. View

5.
Oroszlan S, Henderson L, Stephenson J, Copeland T, Long C, Ihle J . Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus. Proc Natl Acad Sci U S A. 1978; 75(3):1404-8. PMC: 411480. DOI: 10.1073/pnas.75.3.1404. View